{"id":"https://openalex.org/W2095240617","doi":"https://doi.org/10.1158/1538-7445.am2013-2489","title":"Abstract 2489: Proteomic profiling identifies PI3K and DNA repair pathways as potential markers of response to PARP inhibitor BMN673 in SCLC.","display_name":"Abstract 2489: Proteomic profiling identifies PI3K and DNA repair pathways as potential markers of response to PARP inhibitor BMN673 in SCLC.","publication_year":2013,"publication_date":"2013-04-01","ids":{"openalex":"https://openalex.org/W2095240617","doi":"https://doi.org/10.1158/1538-7445.am2013-2489","mag":"2095240617"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2013-2489","doi":"https://doi.org/10.1158/1538-7445.am2013-2489","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2013-2489","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5090831643","display_name":"Robert J. Cardnell","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert J. Cardnell","raw_affiliation_strings":["1MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101904572","display_name":"Ying Feng","orcid":"https://orcid.org/0000-0003-0734-4060","observed_orcids":["https://orcid.org/0000-0003-0734-4060"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ying Feng","raw_affiliation_strings":["2BioMarin Pharmaceutical, Inc., Novato, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2BioMarin Pharmaceutical, Inc., Novato, CA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089771018","display_name":"Lixia Diao","orcid":"https://orcid.org/0000-0001-6995-4492","observed_orcids":["https://orcid.org/0000-0001-6995-4492"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lixia Diao","raw_affiliation_strings":["1MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112534412","display_name":"You Hong Fan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"You Hong Fan","raw_affiliation_strings":["1MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100378341","display_name":"Jing Wang","orcid":"https://orcid.org/0000-0002-5398-0802","observed_orcids":["https://orcid.org/0000-0002-5398-0802","https://orcid.org/0009-0006-4171-5397","https://orcid.org/0000-0002-8911-9555","https://orcid.org/0009-0003-0661-5954"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jing Wang","raw_affiliation_strings":["1MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069152731","display_name":"Yuqiao Shin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yuqiao Shin","raw_affiliation_strings":["2BioMarin Pharmaceutical, Inc., Novato, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2BioMarin Pharmaceutical, Inc., Novato, CA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048865240","display_name":"John Dorrance Minna","orcid":"https://orcid.org/0000-0002-7776-0767","observed_orcids":["https://orcid.org/0000-0002-7776-0767"]},"institutions":[{"id":"https://openalex.org/I867280407","display_name":"The University of Texas Southwestern Medical Center","ror":"https://ror.org/05byvp690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I867280407"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John D. Minna","raw_affiliation_strings":["3UT Southwestern, Dallas, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3UT Southwestern, Dallas, TX","institution_ids":["https://openalex.org/I867280407"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048380048","display_name":"John Victor Heymach","orcid":"https://orcid.org/0000-0001-9068-8942","observed_orcids":["https://orcid.org/0000-0001-9068-8942"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John V. Heymach","raw_affiliation_strings":["1MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5067755477","display_name":"Lauren A. Byers","orcid":"https://orcid.org/0000-0002-0780-2677","observed_orcids":["https://orcid.org/0000-0002-0780-2677"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lauren A. Byers","raw_affiliation_strings":["1MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"73","issue":"8_Supplement","first_page":"2489","last_page":"2489"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.9717000126838684,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.9717000126838684,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.025200000032782555,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/small-cell-lung-cancer","display_name":"small cell lung cancer","score":0.984000027179718},{"id":"https://openalex.org/keywords/parp-inhibitors","display_name":"PARP inhibitors","score":0.8009999990463257},{"id":"https://openalex.org/keywords/parp-1","display_name":"PARP1","score":0.9549999833106995},{"id":"https://openalex.org/keywords/pi3k-akt-mtor-pathway","display_name":"PI3K/AKT/mTOR pathway","score":0.8790000081062317},{"id":"https://openalex.org/keywords/dna-repair","display_name":"DNA repair","score":0.7329999804496765},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.9570000171661377},{"id":"https://openalex.org/keywords/drug-sensitivity","display_name":"drug sensitivity","score":0.5950000286102295},{"id":"https://openalex.org/keywords/cisplatin-sensitivity","display_name":"cisplatin sensitivity","score":0.8489999771118164},{"id":"https://openalex.org/keywords/akt-phosphorylation","display_name":"Akt phosphorylation","score":0.6909999847412109},{"id":"https://openalex.org/keywords/mtor-phosphorylation","display_name":"mTOR phosphorylation","score":0.7649999856948853},{"id":"https://openalex.org/keywords/ercc1","display_name":"ERCC1","score":0.628000020980835},{"id":"https://openalex.org/keywords/dna-pkcs","display_name":"DNA-PKcs","score":0.8029999732971191},{"id":"https://openalex.org/keywords/atm","display_name":"ATM","score":0.7720000147819519},{"id":"https://openalex.org/keywords/fancd2","display_name":"FANCD2","score":0.9679999947547913},{"id":"https://openalex.org/keywords/olaparib","display_name":"olaparib","score":0.8809999823570251},{"id":"https://openalex.org/keywords/rucaparib","display_name":"rucaparib","score":0.9959999918937683}],"concepts":[{"id":"https://openalex.org/C2779962180","wikidata":"https://www.wikidata.org/wiki/Q7083106","display_name":"Olaparib","level":5,"score":0.748877763748169},{"id":"https://openalex.org/C2778480876","wikidata":"https://www.wikidata.org/wiki/Q21112674","display_name":"PARP1","level":5,"score":0.7084135413169861},{"id":"https://openalex.org/C2779309665","wikidata":"https://www.wikidata.org/wiki/Q17917256","display_name":"ERCC1","level":5,"score":0.6655776500701904},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5586705207824707},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5376538038253784},{"id":"https://openalex.org/C134935766","wikidata":"https://www.wikidata.org/wiki/Q210538","display_name":"DNA repair","level":3,"score":0.4769269824028015},{"id":"https://openalex.org/C53227056","wikidata":"https://www.wikidata.org/wiki/Q189152","display_name":"Viability assay","level":3,"score":0.4516732096672058},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.43985873460769653},{"id":"https://openalex.org/C2779138821","wikidata":"https://www.wikidata.org/wiki/Q7118227","display_name":"PARP inhibitor","level":5,"score":0.41942569613456726},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.307717502117157},{"id":"https://openalex.org/C182979987","wikidata":"https://www.wikidata.org/wiki/Q3907241","display_name":"Poly ADP ribose polymerase","level":4,"score":0.28394559025764465},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.14775177836418152},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.11506223678588867},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.11170288920402527},{"id":"https://openalex.org/C82381507","wikidata":"https://www.wikidata.org/wiki/Q416878","display_name":"Polymerase","level":3,"score":0.0},{"id":"https://openalex.org/C104451858","wikidata":"https://www.wikidata.org/wiki/Q2714458","display_name":"Nucleotide excision repair","level":4,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2013-2489","doi":"https://doi.org/10.1158/1538-7445.am2013-2489","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2013-2489","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9922999739646912}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4294309286","https://openalex.org/W2080085348","https://openalex.org/W2105007834","https://openalex.org/W2317040753","https://openalex.org/W2504509590","https://openalex.org/W2598546211","https://openalex.org/W1654311348","https://openalex.org/W2484698394","https://openalex.org/W2098161852","https://openalex.org/W4308027436"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Small":[2],"cell":[3,51,107,127,176,320],"lung":[4,16],"cancer":[5,375],"(SCLC)":[6],"is":[7],"an":[8,352],"aggressive":[9],"malignancy":[10],"that":[11,264,369],"accounts":[12],"for":[13,85,346,472],"13%":[14],"of":[15,46,61,74,96,114,150,173,187,203,228,251,290,296,332,343,393,410,452,463,468],"cancers":[17],"in":[18,49,58,125,167,170,286,314,316,329,337,404,412,458],"the":[19,317,333,347,464,469],"US":[20],"and":[21,53,68,76,90,101,111,121,140,209,234,254,274,305,339,359,379,388,395,445],"has":[22],"a":[23,83,171,381,405],"5-year":[24],"survival":[25],"rate":[26],"<10%.":[27],"Novel":[28],"therapeutic":[29],"approaches":[30],"are":[31],"critically":[32],"needed":[33],"to":[34,63,99,220,244,376,454],"improve":[35],"clinical":[36,279],"outcomes.":[37],"Using":[38],"proteomic":[39],"profiling,":[40],"we":[41,71,325,350],"previously":[42],"identified":[43],"high":[44,225],"levels":[45,202,304,308],"PARP1":[47,80],"expression":[48,113,139,152,185,201,227],"SCLC":[50,62,97,126,175,319,338],"lines":[52,98,128,177],"tumors.":[54],"We":[55,246],"also":[56,247],"demonstrated":[57],"vitro":[59,168,315,330],"sensitivity":[60,142,243,358],"two":[64],"PARP":[65,162,260,283,334,356,377,455],"inhibitors,":[66],"olaparib":[67],"rucaparib.":[69],"Here":[70,324],"explore":[72],"markers":[73,89,116,289,295,342,451],"response":[75,292,398,453],"pathways":[77,448],"modulated":[78],"following":[79,122,259],"inhibition":[81,371,378],"as":[82,449],"basis":[84],"developing":[86],"potential":[87,340,382,450],"predictive":[88,341],"rational":[91],"drug":[92,123,141],"combinations.":[93],"Methods:":[94],"Sensitivity":[95],"BMN673":[100,164,196,291,336,394,411,457],"cisplatin":[102,297,312],"was":[103,117,155,192],"determined":[104,144],"by":[105,129,145,157],"CellTiter-Glo":[106],"viability":[108],"assay.":[109],"Total":[110],"phospho-protein":[112],"200":[115],"measured":[118],"at":[119,257],"baseline":[120,137,226],"treatment":[124,154],"reverse":[130],"phase":[131],"protein":[132,138,151,200,303],"array":[133],"(RPPA).":[134],"Correlations":[135],"between":[136,355,385],"were":[143,211,239],"Spearman":[146],"rank":[147],"correlation.":[148],"Modulation":[149],"post":[153],"assessed":[156],"ANOVA.":[158],"Results:":[159],"The":[160,391],"novel":[161],"inhibitor":[163,261,284,335,357,456],"had":[165],"potent":[166],"activity":[169,285,313,331,392],"panel":[172],"12":[174],"with":[178,194,214,241,271,278,294,299,310,414],"IC50\u2019s":[179],"ranging":[180],"from":[181],"1.7-15nM.":[182],"A":[183],"higher":[184,300],"level":[186],"several":[188],"DNA":[189,205,301,386,446],"repair":[190,302,387,447],"proteins":[191],"associated":[193,240,270,309],"greater":[195,282,311],"sensitivity.":[197],"For":[198],"example,":[199],"ERCC1,":[204],"PKcs,":[206],"ATM,":[207],"FANCD2,":[208],"pChk2":[210],"inversely":[212],"correlated":[213],"IC50":[215],"values":[216,218],"(Rho":[217],"-0.93":[219],"-0.81;":[221],"p\u22640.02).":[222],"In":[223],"contrast,":[224],"phosphorylated":[229],"Akt":[230],"(T308)":[231],"(R=0.91,":[232],"p=0.005)":[233],"pAkt":[235,307],"(S473)":[236],"(R=0.81,":[237],"p=0.02)":[238],"decreased":[242],"BMN673.":[245],"observed":[248],"increased":[249],"phosphorylation":[250],"mTOR,":[252],"Akt,":[253],"S6":[255],"(p<0.02)":[256],"24h":[258],"treatment,":[262],"suggesting":[263,281,368],"PI3K/Akt/mTOR":[265,360],"pathway":[266,361],"activation":[267],"may":[268,372],"be":[269,401],"both":[272],"inherent":[273],"acquired":[275],"resistance.":[276],"Consistent":[277],"studies":[280],"platinum-sensitive":[287],"tumors,":[288],"overlapped":[293],"sensitivity,":[298],"lower":[306],"same":[318],"line":[321],"panel.":[322],"Conclusions:":[323],"demonstrate":[326],"significant,":[327],"single-agent":[328],"response.":[344],"Interestingly,":[345],"first":[348],"time":[349],"show":[351],"inverse":[353],"correlation":[354],"activation.":[362],"This":[363],"observation":[364],"parallels":[365],"recent":[366],"data":[367],"PI3K":[370,389,444],"sensitize":[373],"breast":[374],"suggests":[380],"coordinated":[383],"regulation":[384],"pathways.":[390],"these":[396],"candidate":[397],"biomarkers":[399],"will":[400],"further":[402],"investigated":[403],"Phase":[406],"I":[407],"cohort":[408],"expansion":[409],"patients":[413],"SCLC.":[415,459],"Citation":[416],"Format:":[417],"Robert":[418],"J.":[419],"Cardnell,":[420],"Ying":[421],"Feng,":[422],"Lixia":[423],"Diao,":[424],"You":[425],"Hong":[426],"Fan,":[427],"Jing":[428],"Wang,":[429],"Yuqiao":[430],"Shin,":[431],"John":[432,435],"D.":[433],"Minna,":[434],"V.":[436],"Heymach,":[437],"Lauren":[438],"A.":[439],"Byers.":[440],"Proteomic":[441],"profiling":[442],"identifies":[443],"[abstract].":[460],"In:":[461],"Proceedings":[462],"104th":[465],"Annual":[466],"Meeting":[467],"American":[470],"Association":[471],"Cancer":[473,483],"Research;":[474],"2013":[475],"Apr":[476],"6-10;":[477],"Washington,":[478],"DC.":[479],"Philadelphia":[480],"(PA):":[481],"AACR;":[482],"Res":[484],"2013;73(8":[485],"Suppl):Abstract":[486],"nr":[487],"2489.":[488],"doi:10.1158/1538-7445.AM2013-2489":[489]},"counts_by_year":[],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2016-06-24T00:00:00"}